Digital stories could ease tough transplant decisions for blood cancer patients
NCT ID NCT07263074
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study tests a new approach called CHORDS, which uses short digital stories from past patients and simple values exercises to help people with myeloid cancers think through their decision about a stem cell transplant. About 120 patients will be randomly assigned to receive CHORDS or usual care. The main goal is to see if the program is practical and whether it helps patients feel more involved in their own care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- digital story intervention (CHORDS)
- What this could lead to
- If it works, this could give doctors and patients a new tool to make better, more personal decisions about whether to proceed with a stem cell transplant.
- What could go wrong
- This is a small, early feasibility study, not a large trial. It may not show clear benefits, and the digital stories may not help everyone equally.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOID MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Rochester
RECRUITINGRochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune-Boosting drug aims to outsmart Hard-to-Treat blood cancers
- New pill for tough blood cancers enters first human tests
- New study aims to stop blood cancer relapse after transplant
- New skin test could reveal hidden cancer risks
- New gentle chemo combo after transplant aims to stop leukemia relapse
- Personalized stem cell transplant aims to beat inherited blood cancers